THE Society of Hospital
Pharmacists of Australia (SHPA)
is about to release a survey to
provide data supporting a review
of the future scope of practice
for pharmacy technicians and
assistants working in hospitals.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 11 May 16 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 May 16
CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).